Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01125
Species: Homo sapiens
Position : chr4:111552482-111553989
Year: 2016
Title: A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
Disease Name: --
PMID:  27866707
MONDO:
Tissue: Heart
Tissue Ontology ID: UBERON:0000948
Cell Source: WA07 hESC-CM
CVCL ID:
Cell Type: cardiomyocyte
Cell Ontology ID: CL:0000746
Experiment Type: Enhancer activity assay, TF binding assay, Functional perturbation assay
High Throughput Method: ChIP-seq
Low Throughput Method: Luciferase reporter assay, Tol2-mediated zebrafish transgenic reporter assay, ChIP-qPCR, EMSA, CRISPR-Cas9 genome editing, RT-qPCR, Western blot
About Target Gene
Target gene : PITX2C
About TF
TF name : TFAP2A
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
TFAP2A Caspase Cascade in Apoptosis pid 57
TFAP2A Hs_Corticotropin-releasing_hormone_signaling_pathway_WP2355_90017 wikipathways 41
TFAP2A Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
TFAP2A Hs_Ectoderm_Differentiation_WP2858_89329 wikipathways 56
TFAP2A Hs_Hypothetical_Craniofacial_Development_Pathway_WP3655_88473 wikipathways 5
Enhancer Associated Network
Overlapping Enhancers (hg19) 6 found
Enhancer ID Position Tissue Cell Disease
E_01122 chr4:111552482-111553989 Blood lymphoblastoid cell --
E_01123 chr4:111552482-111553989 Embryo embryonic cell --
E_01124 chr4:111552482-111553989 Heart atrial cardiomyocyte atrial fibrillation
E_01126 chr4:111553098-111553222 Cervix cervical adenocarcinoma cell cervical cancer
E_01127 chr4:111553098-111553222 Heart atrial cardiomyocyte atrial fibrillation
E_01128 chr4:111553098-111553222 Heart cardiomyocyte --
Expression of Target Genes for the Enhancer